Breast Biopsy (Modified Radical Mastectomy) Histopathology in UAE – 550 AED

Executive Summary & Core Metrics

Diagnostic accuracy exceeding 99% through ISO 9001:2015 certified histopathology, full immunohistochemistry (ER/PR/HER2) panel, and optional BRCA1/2 genetic profiling. Board-certified surgical pathologists with breast subspecialty training examine every specimen. Secure cold-chain logistics transport your tissue from the operating suite to our laboratory. Post-test telephonic consultation with clinical guidance is included. Direct insurance billing is supported – verify coverage via WhatsApp at +971 54 548 8731. All services comply with UAE Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields.

Price: 550 AED
Turnaround Time: 6 working days with digital report access
Sample Type: Breast tissue (post-mastectomy)
Methodology: Histopathology + IHC panel (ER, PR, HER2) + optional BRCA1/2
DHA Facility License: 1143 | Dubai Healthcare City

Test Overview & Methodology

The Breast Biopsy (Modified Radical Mastectomy) Histopathology test examines tissue removed during a modified radical mastectomy to detect residual or recurrent breast cancer. Our laboratory employs advanced histopathological techniques with full immunohistochemistry (IHC) for estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) status. Optional genetic profiling for BRCA1/2 mutations is available. This definitive diagnosis guides your oncologist’s personalized treatment plan.

Features	DNA Labs UAE	Routine Histopathology Lab
Precision & Subspecialty	Fellowship-trained surgical pathologists with breast pathology expertise	General pathologist, may lack breast specialization
Methodology	Histopathology + full IHC panel (ER, PR, HER2) & optional genetic testing (BRCA1/2)	Basic H&E staining only
Turnaround Time	6 working days with digital report access	10–14 days, paper report

Physician Insight & Safety Protocols

“A breast biopsy after modified radical mastectomy is a key step in confirming whether cancer remains or has returned. Please always correlate these results with your clinical examination and imaging. I strongly recommend discussing the findings with your oncologist before making any treatment decisions.”

— Mr. Prabhakar Reddy Kalathoor, Specialist Diagnostic Radiology, DHA Registration ID: 61713011

Advisory – When to Seek Immediate Medical Attention

Red Flags:

Severe chest pain or sudden shortness of breath
Heavy bleeding or purulent discharge from the surgical site
Fever above 38°C (100.4°F)

Do not discontinue any prescribed medication without consulting your doctor.

Exclusion Criteria – Contraindications

Active infection at the surgical site
Known severe bleeding disorders (INR > 1.5, platelets < 50,000/mcL)
Pregnancy (for certain histochemical stains)

Patient FAQ & Clinical Guidance

1. Why do I need a breast biopsy after a modified radical mastectomy?

This biopsy identifies any residual or recurrent breast cancer in the chest wall, ensuring timely treatment and monitoring. It also checks hormone receptor and HER2 status to guide ongoing therapy. Clinical follow-up remains essential even with negative results.

2. How is the biopsy sample collected?

Your surgeon collects a tissue sample from the mastectomy site during a follow-up procedure or via a needle biopsy. The procedure is performed under sterile conditions within an accredited hospital facility. Hospital Extraction Only – Sample collection is conducted strictly within an accredited hospital facility; mobile home phlebotomy is disabled for safety.

3. What do the biopsy results mean?

Results indicate presence of cancer cells, receptor status, and HER2 expression to guide personalized treatment. A negative result does not rule out recurrence; clinical follow-up remains essential. Your oncologist will integrate these findings with imaging and clinical examination.

4. How long does it take to get results?

Results are available within 6 working days. You will receive digital report access through our secure patient portal, and a telephonic consultation is included to discuss findings with a clinician.

5. Is insurance accepted for this test?

Yes, we support direct insurance billing for most UAE insurers. Please verify your specific coverage by messaging us on WhatsApp at +971 54 548 8731 prior to the procedure.

UAE Regulatory & Data Privacy Adherence

Regulatory Compliance & Data Protection

Your personal health information is processed in full compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical safety and patient consent protocols adhere to Federal Decree-Law No. 4 of 2016 on Medical Liability. DNA Labs UAE is a DHA-licensed facility (License No. 1143) operating from Dubai Healthcare City.

Clinical & Logistical Metadata

Test Name	Breast Biopsy (Modified Radical Mastectomy) Histopathology
Price (AED)	550
Turnaround Time	6 working days
Sample Type / Matrix	Breast tissue (post-mastectomy) – Hospital Extraction Only
Methodology Used	Histopathology + IHC panel (ER, PR, HER2) + optional BRCA1/2 genetic profiling
ICD-10-CM Code	C50.9
LOINC Code	34597-1
DHA Facility License & Address	License No. 1143 \| Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE